Since we demonstrated a significant difference in the expression levels of indicated lncRNAs and miRNAs in normal tissue and benign prostate hyperplasia, these biomarkers can act as a potential diagnostic biomarker in combination with PSA to increase diagnostic accuracy. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.